Enough. (![[info]](http://l-stat.livejournal.com/img/userinfo.gif){kind=small} lordbrand) wrote in blackfrost, |
I am woefully uninformed, but this makes sense. One thing to keep in mind that that basic business model of pharma is totally wild. HUGE R&D expenditures overall, all relying on patent law - almost solely - to support the huge front-end expenditure.
When you get big time from cash spent to cash in skews like that, it's ripe for corner-cutting. Add in the ever unpredictable FDA and patent process that can completely kill a whole drug family's chances at ever being profitable, the stakes run pretty high.
AM's stakes are the relative decline of American values and the happiness of current marriages. They're not the meth-dealer - they're a shaded window bus service from happy home life to Hell's kitchen.
When you get big time from cash spent to cash in skews like that, it's ripe for corner-cutting. Add in the ever unpredictable FDA and patent process that can completely kill a whole drug family's chances at ever being profitable, the stakes run pretty high.
AM's stakes are the relative decline of American values and the happiness of current marriages. They're not the meth-dealer - they're a shaded window bus service from happy home life to Hell's kitchen.
